Biocytogen Pharmaceuticals (Beijing) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2315 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
31 Oct 24	BuyHK$5,850,002	Veken Holding Group CO., LTD.	Company		1,000,000	HK$5.85
11 Sep 24	BuyHK$4,094,998	Veken Holding Group CO., LTD.	Company		700,000	HK$5.85

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 11 shareholders own 84.06% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.3%	UBS SDIC Fund Management Co., Ltd.	72,937,440	HK$420.1m	0%	1.22%
13.7%	Biocytogen Pharmaceuticals (Beijing) Co., Ltd, ESOP	54,695,160	HK$315.0m	0%	no data
8.04%	CMB International Capital Management (Shenzhen) Co, Ltd.	32,110,920	HK$185.0m	0%	1.45%
7.26%	Jian Ni	29,004,840	HK$167.1m	0%	no data
6.61%	Yuelei Shen	26,394,840	HK$152.0m	0%	no data
6.53%	Astral Eminent Limited	26,088,480	HK$150.3m	0%	no data
5.89%	China Life Private Equity Investment Co., Ltd.	23,519,160	HK$135.5m	0%	1.47%
5.89%	China Life Insurance (Group) Company Limited, Asset Management Arm	23,519,160	HK$135.5m	0%	24.62%
5.08%	BVCF Management Ltd	20,291,400	HK$116.9m	0%	31.94%
4.77%	Shenzhen Zhaoyin Chengzhang Shijiuhao Equity Investment Fund Partnership	19,060,920	HK$109.8m	0%	no data
2.03%	Veken Holding Group CO., LTD.	8,102,580	HK$46.7m	78.9%	no data